Supriya Lifescience Files FY26 BRSR Report

Supriya Lifescience Ltd. has submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26. The report details the company's corporate identity, operational data, employee statistics, and market presence. Key disclosures include its CIN, registered and corporate addresses, contact information, and the financial year covered (April 1, 2025, to March 31, 2026). The company's primary business activity is the manufacturing of Active Pharmaceutical Ingredients, accounting for 98.17% of its turnover. Supriya Lifescience serves a diversified customer base across 28 national and 128 international markets, with exports contributing 82% of its total turnover. The report also outlines employee demographics, including gender representation, and notes the absence of differently-abled employees and workers.